Tumor Immunotherapy Using Gene-Modified Human Mesenchymal Stem Cells Loaded into Synthetic Extracellular Matrix Scaffolds

Mesenchymal stem cells (MSCs) are appealing as gene therapy cell vehicles given their ease of expansion and transduction. However, MSCs exhibit immunomodulatory and proangiogenic properties that may pose a risk in their use in anticancer therapy. For this reason, we looked for a strategy to confine...

Descripción completa

Detalles Bibliográficos
Autores principales: Compte, Marta, Cuesta, Ángel M, Sánchez-Martín, David, Alonso-Camino, Vanesa, Vicario, José Luís, Sanz, Laura, Álvarez-Vallina, Luís
Formato: Texto
Lenguaje:English
Publicado: Wiley Subscription Services, Inc., A Wiley Company 2009
Materias:
Translational and Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729675/
https://www.ncbi.nlm.nih.gov/pubmed/19096041
http://dx.doi.org/10.1634/stemcells.2008-0831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729675/
https://www.ncbi.nlm.nih.gov/pubmed/19096041
http://dx.doi.org/10.1634/stemcells.2008-0831

Ejemplares similares